Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AstraZeneca Sees Growth Opportunities in Japan As Population Continues To Age

This article was originally published in PharmAsia News

Executive Summary

AstraZeneca KK’s young president Gabriel Baertschi is eying more partnerships for cardiovascular, oncology and respiratory therapies in Japan.

You may also be interested in...



Japan, Facing Rising Health Care Costs, May Slash Generic Drug Prices

Japan may try to accelerate the increased usage of generic drugs by drastically reducing prices, part of an effort to slash skyrocketing health care costs at a time when the country’s public debt is reaching a record high.

Kyowa Hakko Kirin, Ultragenyx To Develop Treatment For X-linked Hypophosphatemia

Kyowa Hakko Kirin is committed to expansion, and the deal with Ultragenyx for a first-in-class therapy of a rare bone disorder is small but establishes a clinical trial foothold overseas

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

SC083268

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel